Human factors study validates Bmab 1200 autoinjector for ustekinumab delivery
The Bmab 1200 autoinjector showed high usability and safety in a human factors validation study with 100% successful unaided injections.
Therapeutic Area
Therapeutic area intelligence for Psoriasis and Autoimmune Diseases with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.